Dr. Van Tine on Sequencing Therapies in GIST

Dr. Van Tine Discusses Potential Novel Treatment Modalities for SarcomaПодробнее

Dr. Van Tine on Collaboration and Clinical Trials in Uterine SarcomaПодробнее

Brian Van Tine, MD, considers the role of real-world outcomes in the treatment of sarcomaПодробнее

Potential Novel Treatment Modalities for SarcomaПодробнее

Dr. Van Tine on Trabectedin for Leiomyosarcoma and LiposarcomaПодробнее

Dr. Van Tine on Arginine Deiminase for SarcomasПодробнее

Dr. Van Tine Discusses the Development of Olaratumab in SarcomaПодробнее

Dr. Van Tine Discusses Identifying Biomarkers in SarcomasПодробнее

Therapeutic strategy in GIST tumorsПодробнее

Progression of Metastatic GISTПодробнее

Practices across Expert Sarcoma CentersПодробнее

ASCO 2013 - Brian Van Tine M.D., PH.D., Molecular ProfilingПодробнее

AL3818 hydrochloride monotherapy in subjects with metastatic or advanced synovial sarcomaПодробнее

An Analysis of SARC021Подробнее

Optimizing treatment approaches for the management of GISTПодробнее

Dr. Van Tine - A Medical Oncologist Perspective on STARПодробнее

Dr. Keedy on Regorafenib for the Treatment of GISTПодробнее

Future Directions in Soft Tissue SarcomaПодробнее

Combination Strategies: MEK Inhibition and Immunotherapy in GISTПодробнее